주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기
통합검색
로그인
고객센터
주요메뉴
질환포커스
세계의약뉴스
국내의약뉴스
성상변경내역
약제급여기준 개정내역
제약업계 소식
메디컬포커스
컨퍼런스
CME
근골격계
남성건강
내분비대사계
면역계
비뇨기계
뇌심혈관계
종양
호흡기계
감각기관계
중추신경계
소화기계
감염계
혈액 및 조혈계
미용
기타
최근 해외학술대회의 주요 발표내용을 제공합니다.
컨퍼런스 커버리지
European Association of Urology 40th Annual Congress (EAU25)
21 March - 24 March, 2025, Spain
Clomipramine-sildenafil combo tied to better outcomes in men with PE
2025-05-29
The combination regimen of clomipramine and sildenafil led to better outcomes than clomipramine or sildenafil alone in men with premature ejaculation (PE) without erectile dysfunction (ED), according to a study presented at EAU25.
LHRH analogues vs tE2 patches: Which work best in men with locally advanced prostate cancer?
2025-05-29
The use of transdermal oestradiol (tE2) or oestrogen patches helps suppress testosterone and prostate-specific antigen (PSA) in men with locally advanced prostate cancer, with similar efficacy to that of luteinizing hormone-releasing hormone (LHRH) analogues, reports a study presented at EAU 2025.
More prostate cancers caught with transperineal vs transrectal biopsy
2025-05-29
When sampling prostate tissue using ultrasound guidance and local anaesthesia, going by the transperineal (LATP) approach results in greater detection of clinically significant prostate cancers relative to the transrectal (TRUS) approach, as shown in the TRANSLATE trial.
Nerve-sparing technique preserves erectile function after RARP
2025-05-29
A nerve-sparing technique decreases erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer in a phase III study.
Noninvasive approach may be sufficient for OAB management in women
2025-05-29
Augmenting comprehensive clinical assessment (CCA) with invasive urodynamic investigations does not appear to benefit women with refractory overactive bladder (OAB) symptoms in the FUTURE* study presented at EAU25.
Novel urine test shows promise for kidney cancer recurrence surveillance
2025-05-29
The urine GAGome score appears to be a promising biomarker for detecting clear cell renal cell carcinoma (ccRCC) recurrence, findings from the AURORAX-0087A trial suggest.
Self-efficacy high among survivors of prostate cancer
2025-05-29
Long-term prostate cancer survivors report high levels of self-efficacy, but the contrary is true for subgroups who are facing some challenges, a study presented at EAU 2025 has found.
Shockwave therapy plus tadalafil beneficial to Asians with ED
2025-05-29
In the treatment of mild to moderate erectile dysfunction (ED), low-intensity extracorporeal shockwave therapy combined with tadalafil helps improve outcomes, according to the preliminary results of a study from China.
Smoking, ASA score predict long-term failure after urethroplasty
2025-05-29
Men with urethral stricture disease who underwent urethroplasty may experience recurrence long after the procedure, according to a study presented at EAU 2025.
TB vax primer augments BCG-induced immune response in bladder cancer patients
2025-05-29
Initial results of the phase I RUTIVAC-1 study show the potential of two doses of a tuberculosis (TB) vaccine given after surgery but before standard BCG* treatment to boost immunity and reduce the odds of recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).
1
최근 본 콘텐츠
최근 본 콘텐츠가 없습니다
관심제품
관심콘텐츠
